DrugPatentWatch Database Preview
Details for Patent: RE29892
Summary for Patent: RE29892
|Title:|| Composition and method of treating dopamine deficiency in brain tissue|
|Abstract:||The dopamine content in brain tissue of animals is increased by administering to the animal L-dopa or its salts in combination with L-.alpha.-hydrazino-.alpha.-lower alkyl-3,4-dihydroxyphenyl propionic acid or its salts .[.or .alpha.-hydrazino-3,4-dihydroxyphenyl propionic acid or its salts.].. The increased dopamine content in brain tissue tends to alleviate some of the symptoms caused by Parkinsonism and similar diseases.|
|Inventor(s):|| Bayne; Gilbert M. (Lansdale, PA) |
|Assignee:|| Merck & Co. Inc. (Rahway, NJ) |
Patent Claim Types:|
see list of patent claims
|Use; Composition; Delivery; |
No matches for this query
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.